Tactile Systems Technology, Inc. (TCMD)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 187 | 208 | 247 | 274 | 293 | 330 | 350 | 362 |
| Operating profit | $m | 29 | 35 | ||||||
| Net profit | $m | -1 | -12 | -18 | 29 | 17 | 19 | 25 | 26 |
| EPS reported | $ | 0.82 | 1.08 | ||||||
| Operating cashflow per share | $ | 1.87 | 1.86 | ||||||
| Capex per share | $ | 0.10 | 0.13 | ||||||
| FCF per share | $ | 1.77 | 1.73 | ||||||
| Free cash flow | $m | 40 | 27 | ||||||
| Net debt | $m | -71 | -70 | ||||||
| Book value equity | $m | 219 | 224 | ||||||
| Book value per share | $ | 9.40 | 9.71 | ||||||
| Number of shares | m | 23.3 | 23.06 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 35.37 | 25.93 | ||||||
| P/B LTM | x | 3.03 | 2.96 | ||||||
| P/S LTM | x | 2.01 | 1.89 | ||||||
| P/FCF LTM | x | 16.41 | 24.83 | ||||||
| EV/EBITDA LTM | x | 15.27 | 13.50 | ||||||
| EV/Sales LTM | x | 1.81 | 1.77 | ||||||
| Earnings Yield LTM | % | +2.83% | +3.86% | ||||||
| FCF Yield | % | +6.10% | +4.03% | ||||||
| Quality | |||||||||
| ROE | % | +8.72% | +9.70% | ||||||
| ROIC | % | +7.55% | +7.93% | ||||||
| Operating margin | % | +8.89% | +9.40% | ||||||
| Gross margin | % | +75.17% | +75.68% | ||||||
| FCF/Sales | % | +12.27% | +11.38% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +17.14% | +54.29% | ||||||
| Sales Growth YoY | % | +12.47% | +19.57% | ||||||
| Net Income Growth YoY | % | +12.54% | +46.61% | ||||||
| FCF Growth | % | +5.99% | -29.96% | ||||||
| Operating Profit Growth | % | +32.00% | +57.93% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 2.53 | 1.86 | ||||||
| Net Debt/EBITDA | x | -1.73 | -1.44 | ||||||
| EBIT/Net interest | x | 28.21 | 71.91 | ||||||
| Net debt/market cap | % | +1.92% | +1.78% | ||||||
| Net debt/Equity | x | -0.32 | -0.31 | ||||||
| Gross debt/equity | x | 0.07 | 0.06 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Tactile Systems Technology, Inc. (TCMD)
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free